Pilot Study: Relaxation and Guided Imagery in Hispanic Persons Diagnosed With Fibromyalgia

This study has been completed.
Sponsor:
Collaborator:
Sigma Theta Tau International (Nursing Honor Society)
Information provided by:
Florida International University
ClinicalTrials.gov Identifier:
NCT00512590
First received: August 3, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
  Purpose

The purpose of this pilot study was to test the effects of a 10-week relaxation and guided imagery intervention on pain perception, functional status, self-efficacy and levels of distress in Hispanic adults diagnosed with fibromyalgia.


Condition Intervention
Fibromyalgia
Pain
Functional Status
Self-Efficacy
Distress
Behavioral: Relaxation and Guided Imagery

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effects of Guided Imagery on Pain, Distress, Functional Status and Self-Efficacy in Hispanics Diagnosed With Fibromyalgia

Resource links provided by NLM:


Further study details as provided by Florida International University:

Primary Outcome Measures:
  • Pain as measured by Short-Form McGill Pain Questionnaire [ Time Frame: 10 weeks ]

Secondary Outcome Measures:
  • Functional Status as measured by the Fibromyalgia Impact Questionnaire [ Time Frame: 10 weeks ]
  • Self-Efficacy as measured by the Arthritis Self-Efficacy Scale adapted for FM [ Time Frame: 10 weeks ]
  • Distress as measured by the 17-item Mental Health Inventory [ Time Frame: 10 weeks ]

Enrollment: 14
Study Start Date: April 2005
Study Completion Date: June 2006
Arms Assigned Interventions
Experimental: Experimental Behavioral: Relaxation and Guided Imagery

The intervention consisted of 3 relaxation and guided imagery audiotapes used in a proscribed order for 6 weeks and used in any order for weeks 7 through 10.

Protocol: Tape 1: Basic Relaxation used for weeks 1 and 2. Tape 2: Pleasant Scene Imagery to elicit sensory involvement for enhanced sense of overall well-being; used for weeks 3 and 4. Tape 3: End-State Imagery designed to facilitate improved symptom management; used for weeks 5 and 6. Any of the tapes used as often as desired but at least once daily for weeks 7 to 10.


Detailed Description:

Fibromyalgia (FM), a chronic widespread pain condition with an unknown pathogenesis and no known cure, affects 2 to 4 million persons in the adult US population. One of the most common conditions seen in rheumatology clinics world wide, including the US, Mexico, and Spain, FM is accompanied by various co-occurring symptoms such as fatigue, disturbed sleep, stiffness and depression. While studies of fibromyalgia in Hispanics have been reported in Spain, Brazil and Argentina, very few such studies have been reported in the United States. This gap exists despite data indicating that there are a reported 16 million Hispanics with rheumatic diseases in the US and that Hispanics (self-identified) form the fastest growing minority group in this country.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • ages 18 and older
  • diagnosis of fibromyalgia based on the American College of Rheumatology criteria and documented by the patient's primary physician
  • a minimum of a 6th grade education level
  • an ability to understand and sign the consent form and understand and complete the intervention (pencil and paper) assignments.

Exclusion Criteria:

  • presence of other systemic rheumatologic conditions such as rheumatoid arthritis, lupus, and/or Sjogren's Disease
  • adequate functional status as indicated by a Fibromyalgia Impact Questionnaire score < 20
  • inadequate cognitive status as evidenced by a Mini-Mental State Exam score < 25
  • history of epilepsy
  • major communicative disorder.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00512590

Locations
United States, Florida
Florida International University
Miami, Florida, United States, 33199
Sponsors and Collaborators
Florida International University
Sigma Theta Tau International (Nursing Honor Society)
Investigators
Principal Investigator: Victoria Menzies, PhD, APRN-BC Florida International University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00512590     History of Changes
Other Study ID Numbers: Menzies-1
Study First Received: August 3, 2007
Last Updated: August 3, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by Florida International University:
fibromyalgia
relaxation
imagery
pain
functional status
self efficacy
minority health

Additional relevant MeSH terms:
Fibromyalgia
Myofascial Pain Syndromes
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on April 21, 2014